findmyKOL
Clinical trialNCT07606365Not, yet, recruitingPhase 2Interventional

A Study in Adults With Geographic Atrophy

SponsorSitala Bio LTDEnrollment300Geographic Atrophy
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this clinical research study is to look at how safe STL303 is and whether it works when given to people with Geographic Atrophy (GA) secondary to Age-related Macular Degeneration (AMD). Geographic atrophy secondary to AMD is a condition where cells in the back part of the eye slowly die, causing a blurry, or missing spot in the centre of vision.

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

60 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Buenos Aires Macula S.A

    Buenos Aires, Buenos Aires, Argentina

  • Centro Medico Viamonte Srl

    Buenos Aires, Buenos Aires, Argentina

  • Centro de Ojos Quilmes

    Quilmes, Buenos Aires, Argentina

  • Centro Oftalmologico Dr. Charles S.A.

    Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina

  • Hospital Britanico de Buenos Aires

    Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina

  • Instituoto Oftalmologico de Buenos Aires S.A.

    Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina

  • Centro Privado de Ojos

    Ciudad Autonoma Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina

  • Imoc Instituto de Microcirugia Ocular Cordoba

    Córdoba, Córdoba Province, Argentina

  • Centrovision Mendoza Sa

    Mendoza, Mendoza Province, Argentina

  • Centro de la Vision

    Salta, Salta Province, Argentina

  • Grupo Laser Visión - Rosario Eximer Laser Visión

    Rosario, Santa Fe Province, Argentina

Australia
  • Sydney Eye Hospital

    Sydney, New South Wales, Australia

  • Sydney West Retina

    Westmead, New South Wales, Australia

  • Queensland Eye Institute

    South Brisbane, Queensland, Australia

  • Adelaide Eye and Retina Centre

    Adelaide, South Australia, Australia

  • Cerulea Pty Ltd

    East Melbourne, Victoria, Australia

  • Royal Melbourne Hospital

    Parkville, Victoria, Australia

Czechia
  • Oftex, S.R.O.

    Pardubice, Prague, Czechia

  • Axon Clinical S.R.O.

    Prague, Prague, Czechia

  • Fakultni Nemocnice Kralovske Vinohrady

    Prague, Prague, Czechia

Poland
  • Szpital Swietego Lukasza S. A.

    Bielsko-Biala, Poland

  • Prywatna Klinika Okulistyczna Oftalmika

    Bydgoszcz, Poland

  • Specjalistyczny Osrodek Okulistyczny Oculomedica

    Bydgoszcz, Poland

  • Clinical Medical Research Sp. Z O.O.

    Katowice, Poland

  • Specjalistyczna Praktyka Lekarska Prof. Edward Wylęgała

    Katowice, Poland

  • Centrum Medyczne Dietla 19

    Krakow, Poland

  • Centrum Diagnostyki I Mikrochirurgii Oka Lens

    Olsztyn, Poland

  • Poznanskie Centrum Wzroku Sp Z O O

    Poznan, Poland

  • Centrum Zdrowia Mdm

    Warsaw, Poland

  • Centrum Medyczne

    Wałbrzych, Poland

Switzerland
  • Ente Ospedaliero Cantonale

    Bellinzona, Switzerland

  • Augenarzte Bern Zentrum Marktgasse

    Bern, Switzerland

  • Berner Augenklinik

    Bern, Switzerland

  • Vista Augenklinik Binningen

    Binningen, Switzerland

  • Swiss Visio Montchoisi

    Lausanne, Switzerland

  • Stadtspital Triemli

    Zurich, Switzerland

United Kingdom
  • the Retina Clinic London

    London, Greater London, United Kingdom

  • Southampton General Hospital

    Southampton, Hampshire, United Kingdom

  • University Hospitals of Leicester Nhs Trust

    Leicester, Leicestershire, United Kingdom

  • Royal Victoria Infirmary

    Newcastle upon Tyne, Tyne & Wear, United Kingdom

20 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboSTL303
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2026
Primary completion
31 Jul 2028
Completion
31 Aug 2029
Last update posted
28 May 2026
Registered enrollment
300
Registry id
NCT07606365

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.